A detailed history of Iq Eq Fund Management (Ireland) LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Iq Eq Fund Management (Ireland) LTD holds 5,439 shares of ABBV stock, worth $932,897. This represents 0.11% of its overall portfolio holdings.

Number of Shares
5,439
Previous 4,207 29.28%
Holding current value
$932,897
Previous $651,000 52.07%
% of portfolio
0.11%
Previous 0.08%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$159.82 - $182.1 $196,898 - $224,347
1,232 Added 29.28%
5,439 $990,000
Q4 2023

Feb 09, 2024

SELL
$137.6 - $154.97 $856,560 - $964,688
-6,225 Reduced 59.67%
4,207 $651,000
Q3 2023

Oct 18, 2023

SELL
$133.59 - $154.65 $242,599 - $280,844
-1,816 Reduced 14.83%
10,432 $1.55 Million
Q1 2023

May 10, 2023

SELL
$144.61 - $166.54 $183,799 - $211,672
-1,271 Reduced 9.4%
12,248 $1.95 Million
Q4 2022

Feb 08, 2023

BUY
$138.31 - $165.87 $52,557 - $63,030
380 Added 2.89%
13,519 $2.19 Million
Q3 2022

Oct 26, 2022

SELL
$134.21 - $153.93 $208,562 - $239,207
-1,554 Reduced 10.58%
13,139 $1.76 Million
Q2 2022

Aug 03, 2022

BUY
$137.62 - $174.96 $42,937 - $54,587
312 Added 2.17%
14,693 $2.25 Million
Q1 2022

Apr 28, 2022

SELL
$131.98 - $163.75 $559,463 - $694,136
-4,239 Reduced 22.77%
14,381 $2.33 Million
Q4 2021

Feb 02, 2022

SELL
$107.43 - $135.93 $391,689 - $495,600
-3,646 Reduced 16.37%
18,620 $2.52 Million
Q3 2021

Oct 27, 2021

SELL
$106.4 - $120.78 $606,586 - $688,566
-5,701 Reduced 20.38%
22,266 $2.4 Million
Q2 2021

Jul 19, 2021

BUY
$105.21 - $117.21 $433,675 - $483,139
4,122 Added 17.29%
27,967 $3.15 Million
Q1 2021

May 11, 2021

BUY
$102.3 - $112.62 $1.14 Million - $1.26 Million
11,182 Added 88.3%
23,845 $2.58 Million
Q4 2020

Jan 29, 2021

BUY
$80.49 - $108.67 $36,542 - $49,336
454 Added 3.72%
12,663 $1.36 Million
Q3 2020

Oct 22, 2020

BUY
$85.91 - $100.83 $33,848 - $39,727
394 Added 3.33%
12,209 $1.07 Million
Q2 2020

Jul 22, 2020

SELL
$73.37 - $98.18 $15,114 - $20,225
-206 Reduced 1.71%
11,815 $1.16 Million
Q1 2020

May 05, 2020

BUY
$64.5 - $97.79 $15,673 - $23,762
243 Added 2.06%
12,021 $916,000
Q4 2019

Feb 06, 2020

SELL
$72.13 - $90.25 $79,559 - $99,545
-1,103 Reduced 8.56%
11,778 $1.04 Million
Q2 2019

Jul 19, 2019

BUY
$65.7 - $83.98 $169,834 - $217,088
2,585 Added 25.11%
12,881 $936,000
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $31,118 - $34,594
350 Added 3.52%
10,296 $1 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $892,951 - $1.06 Million
9,946 New
9,946 $345,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Iq Eq Fund Management (Ireland) LTD Portfolio

Follow Iq Eq Fund Management (Ireland) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iq Eq Fund Management (Ireland) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Iq Eq Fund Management (Ireland) LTD with notifications on news.